[Clinical effect of a new saluretic drug: ethacrynic acid].
D058186:Acute Kidney Injury / Q000188:drug therapy*; D003919:Diabetes Insipidus / Q000188:drug therapy; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000627:therapeutic use*; D004487:Edema / Q000628:therapy*; D004573:Electrolytes / Q000378:metabolism; D004976:Ethacrynic Acid / Q000627:therapeutic use*; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D009584:Nitrogen / Q000097:blood
D004232:Diuretics; D004573:Electrolytes; D006852:Hydrochlorothiazide; D005665:Furosemide; D004976:Ethacrynic Acid; D009584:Nitrogen
Effetto clinico di un nuovo farmaco saluretico, l'acido etacrinico.